Citadel Advisors - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 68 filers reported holding STOKE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$321,977
-84.5%
81,720
-58.2%
0.00%
Q2 2023$2,076,017
+4.7%
195,298
-17.9%
0.00%
Q1 2023$1,982,249
-34.7%
237,965
-27.7%
0.00%
-100.0%
Q4 2022$3,037,649
-12.9%
329,106
+21.1%
0.00%0.0%
Q3 2022$3,489,000
+110.9%
271,781
+117.0%
0.00%
Q2 2022$1,654,000
-38.9%
125,237
-2.6%
0.00%
-100.0%
Q1 2022$2,706,000
+1239.6%
128,532
+1426.1%
0.00%
Q4 2021$202,000
-81.3%
8,422
-80.2%
0.00%
Q3 2021$1,083,000
-63.1%
42,567
-51.2%
0.00%
Q2 2021$2,936,000
+68.5%
87,232
+94.6%
0.00%
Q1 2021$1,742,000
+45.0%
44,830
+131.1%
0.00%
Q4 2020$1,201,000
+149.2%
19,400
+34.7%
0.00%
Q3 2020$482,000
+11.6%
14,400
-23.7%
0.00%
Q1 2020$432,000
+45.9%
18,865
+80.3%
0.00%
Q4 2019$296,000
-89.8%
10,465
-89.5%
0.00%
-100.0%
Q2 2019$2,911,00099,8180.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$562,187,00075.80%
RTW INVESTMENTS, LP 3,544,248$118,697,0002.86%
Cormorant Asset Management, LP 1,537,807$51,501,0001.98%
Redmile Group, LLC 2,549,506$85,383,0001.57%
Birchview Capital, LP 40,000$1,340,0000.45%
HighVista Strategies LLC 17,082$572,0000.42%
Perceptive Advisors 671,978$22,505,0000.33%
GILDER GAGNON HOWE & CO LLC 1,490,153$49,905,0000.31%
Artal Group S.A. 270,750$9,067,0000.22%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 323$11,0000.20%
View complete list of STOKE THERAPEUTICS INC shareholders